The global peripheral stent market is booming, projected to reach $3.85 billion by 2033 with a 5.5% CAGR. Driven by rising PAD prevalence and technological advancements in drug-eluting stents (DES), this market analysis reveals key trends, regional insights, and leading companies like Medtronic, Boston Scientific, and Abbott. Discover the future of peripheral artery disease treatment.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.